Market View 30th June, 2025

View on market: Volatility persists, eagerly searching for growth

In Asia, markets showed mixed trends. Japan’s stock markets were strong, while South Korea’s market saw a slight decline. Australian shares edged up a little, but futures in Hong Kong slipped. Indian stock markets ended higher on Friday, supported mainly by gains in Jio Financial Services and Asian Paints. Both major indices ended the week strong, helped by a rally in financial stocks. This marked the best weekly performance in about a month and a half. In the US, stock markets reached record highs by the end of the week. This came as tensions in the Middle East appeared to ease, and the economy continued to show strength with low inflation. Major US indices, including the S&P 500, Nasdaq, and Dow Jones, all posted solid gains to close the week. Overall, global markets showed optimism, supported by calm geopolitical conditions and hopes of economic stability.

Economic Calendar:

• USD: S&P Global Manufacturing PMI (June) on 01^st July 2025.
• IND: S&P Global Services PMI (June) on 3^rd July 2025.
• USD: Crude Oil Inventories on 2^nd July 2025.
• IND: Foreign Reserves USD on 4^th July 2025.

 

IPO Watch:

Brokerage Radar:

INVESTEC ON SBFC FINANCE:

Initiate Buy with target price of Rs 135, Strength in structure, growth restrained, Strong franchise in secured MSME segment, Achieved 40% AUM CAGR over past 5-years with improving profitability and stable asset quality.

NOMURA ON TORRENT PHARMA:

Maintain Neutral with target price of Rs 3,580, Acquisition will not be a surprise to us, as inorganic expansion, particularly in India, has been a key strategy for Torrent, Investors are likely to take comfort that Torrent has been successful in past acquisitions as they have been value accretive, In the case of JB, the India product portfolio is complementary to that of Torrent.

CITI ON RBL BANK:

Maintain Buy; Hike target price to Rs 285 from Rs 230, Adding upside 90-day catalyst watch, Expecting RoA trajectory improvement to 45-50 bps driven by much awaited normalization of credit cost, Stress in JGL/credit card to further subside in Q1, Slippages to moderate to 4.5% Vs 4.7% in Q4.

CLSA ON UNO MINDA:

Initiate outperform target price: Rs 1,304, Set To Deliver Industry-Beating Growth With Improving ROCE, Industry Revival Plus Portfolio Diversification To Drive Robust Earnings Growth, Could Reinvest Bulk Of FCF In M&A Or Fresh Projects To Scale Up Fast, See Co As A High Growth Compounding Play With A Lean Balance Sheet.

International Markets:

U.S & Europe:

*As per 30^thJune.

Asian markets:

Stocks strong on Chart:

Commodities & Currency:

FIIs & DIIs:

News Updates:

Torrent Pharma:	To acquire controlling stake in JB Chemicals at equity valuation of Rs 25,689 crore, followed by merger.
Hind Rectifiers:	Won Rs 127 crore order from Indian Railways to be executed by FY27.
Titagarh Rail Systems:	Secured Rs 430 crore order for 12 additional Pune Metro trainsets.
Interarch Building:	Has received Rs 77 crore construction order from Amara Raja Infra.
BHEL:	Has received Rs 6,500 crore order from Adani Power for 6 thermal units of 800 MW.

Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 214 

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Vindhyachal Prasad, Elite Wealth Limited, vindhyachal@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

• all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
• No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale. Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. Reports
2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

• EWL or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
• EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

2. 2. Compensation

• EWL or its associates have not received any compensation from the subject company in the past twelve months;
• EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
• EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
• EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
• EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research

3. In respect of Public Appearances

• EWL or its associates have not received any compensation from the subject company in the past twelve months;
• The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL